Zevra Therapeutics, Inc. (ZVRA): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-16, first reflected in a filing dated 2021-03-12. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

57.26M
Year ended 2025-12-31
2020-12-31: 3.98M2021-12-31: 29.77M2024-12-31: 46.25M2025-12-31: 57.26M57.26M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3157.26M+23.8%2026-03-09, From 2025-01-01
2024-12-3146.25Mn/c2026-03-09, From 2024-01-01
No annual figure between 2021-12-31 and 2024-12-31.
2021-12-3129.77M+647.7%2022-03-31, From 2021-01-01
2020-12-313.98Mn/a2022-03-31, From 2020-01-01